← Back to headlines
B. Riley Lifts Price Target on Theravance Biopharma (TBPH) to $17 From $14
B. Riley has increased its price target for Theravance Biopharma (TBPH) from $14 to $17.
20 Apr, 00:09 — 20 Apr, 00:09
Sources
Showing 1 of 1 sources
B. Riley has increased its price target for Theravance Biopharma (TBPH) from $14 to $17.
